2022•Annals of OncologyOpen access

23P Combination chemotherapy and hormone therapy (CHT) in patients with hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC): A single-centre retrospective analysis

K. Bajaj, Deep Vora, P. Parab, Hareem Shaikh, S. Gulia, Sushmitha Rath, J. Bajpai, T. Shet, S. DESAİ, Palak B. Thakkar Popat, R. Rajan, N.S. Nair, S. Joshi, R. Pathak, R. Sarin, Y. Kembhavi, Swapnil Ulhas Rane, J. Ghosh, R. Badwe, S. Gupta

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Metastatic breast cancer, Hormone receptor, Oncology, Breast cancer, Hormone therapy, Internal medicine, Chemotherapy